Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that a unique target-like hair regrowth pattern in alopecia areata may be more common than thought and should be properly identified.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Avicennia Marina extract and avicequinone C can reduce hair loss hormone production and increase hair growth factors, suggesting they could be used to treat androgenic alopecia.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

A 55-year-old woman with several health conditions did not see hair regrowth after a transplant.

Frontal fibrosing alopecia causes hairline recession and eyebrow loss in postmenopausal women.

Some vaccines, like the hepatitis B vaccine, might be linked to the hair loss condition Alopecia Areata, but more research is needed.

Platelet-rich plasma injections are an effective treatment for hair loss with minimal side effects.

Finasteride may help postmenopausal women with hair loss but is not effective for all and should be used cautiously in premenopausal women.

The document concludes that non-scarring alopecias can be reversed, but scarring alopecias cause permanent hair loss.

Doctors use their experience to choose treatments for scarring hair loss because it's hard to diagnose and treat.

The document concludes that proper diagnosis and treatment of nonscarring alopecias can improve quality of life and hair regrowth is possible as the hair follicle remains intact.

Temporal triangular alopecia is a lifelong condition with hairless patches on the side of the head that may be present from birth.

Men with male pattern baldness may have a higher risk of heart disease due to increased levels of a specific lipid in their blood.

The document concludes that doctors should recognize congenital triangular alopecia to avoid unnecessary treatments, as it does not respond to steroids like alopecia areata does.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Hair loss can be treated with medications like minoxidil and finasteride or surgery, but treatment effectiveness varies by alopecia type and accurate diagnosis is important.

Dutasteride 0.5mg improves hair growth in 78% of people with hair loss, but may cause sexual problems in some.

Erbium YAG laser treatment, combined with conventional therapy, can effectively reduce hair loss and promote hair growth in men with androgenetic alopecia.

Hair transplant works well, but needs more research for better results.

In Pakistan, men with more severe hair loss often have a higher BMI.

PRP therapy can be effective for early-stage common hair loss, with most patients seeing improvement, but there are inconsistencies in treatment methods.

Sulfotransferase SULT1A1 activity may predict minoxidil treatment success for hair loss.

Platelet-rich plasma therapy is more effective than minoxidil lotion for increasing hair count in men with hair loss, with mild side effects and high satisfaction.

Found key genes affecting hair loss, immune response, and skin development; more research needed for better treatments.

Estradiol-rich plasma can increase hair density faster and more effectively in male pattern baldness treatment than regular plasma.

New 5% minoxidil solution improves scalp hydration, reduces redness, and may be safer for sensitive users.

Microneedling with platelet-rich plasma can cause temporary, painful lymph node swelling in some patients.

Trichoscopy helps diagnose and monitor hair loss, showing different signs at various stages of hair thinning.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.